146 related articles for article (PubMed ID: 1807107)
1. [Superficial tumor of the bladder with associated carcinoma in situ: new occurrences and increase of tumor stage].
Ojea Calvo A; Nogueira March JL; Figueiredo L; Jamardo D; Benavente J; Castro M
Actas Urol Esp; 1991; 15(2):139-42. PubMed ID: 1807107
[TBL] [Abstract][Full Text] [Related]
2. [Superficial carcinoma of the bladder. The pT1 G3 tumor: progression, recurrence, and survival. Treatment].
Nogueira March JL; Ojea Calvo A; Castro Iglesias AM; RodrÃguez Iglesias B
Actas Urol Esp; 1992 Oct; 16(9):682-90. PubMed ID: 1488920
[TBL] [Abstract][Full Text] [Related]
3. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
4. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
5. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
Guney S; Guney N; Canogullari Z; Ergenekon E
Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP
J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
[TBL] [Abstract][Full Text] [Related]
7. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
8. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
[TBL] [Abstract][Full Text] [Related]
9. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
10. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.
Raitanen MP; Tammela TL
Ann Chir Gynaecol; 1995; 84(1):37-41. PubMed ID: 7645909
[TBL] [Abstract][Full Text] [Related]
11. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
Flamm J
Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
[TBL] [Abstract][Full Text] [Related]
13. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
14. [Nucleolar organizers in superficial bladder tumors. Prognostic analysis of 37 observations].
Clement T; Visseaux-Coletto B; Adnet JJ; Ploton D; Lardennois B
Prog Urol; 1991 Apr; 1(2):216-29. PubMed ID: 1844824
[TBL] [Abstract][Full Text] [Related]
15. [Bladder tumors in young patients].
Aboutaieb R; Dakir M; Sarrf I; el Moussaoui A; Bennani S; el Mrini M; Meziane F; Benjelloun S
Prog Urol; 1998 Feb; 8(1):43-6. PubMed ID: 9533150
[TBL] [Abstract][Full Text] [Related]
16. [Studies on multiple mucosal biopsy in patients with bladder cancer. 2. Evaluation on the relationship between the results of multiple mucosal biopsy and recurrence, and the clinical course of cases with carcinoma in situ and micro-invasion of carcinoma in situ].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1633-47. PubMed ID: 3825813
[TBL] [Abstract][Full Text] [Related]
17. [Tumors of the bladder in women. Epidemiologic and therapeutic aspects. Apropos of 40 cases].
Rabii R; el Moussaoui A; Rais H; Joual A; Debbagh A; el Mrini M; Benjelloun S
Ann Urol (Paris); 1998; 32(3):166-71. PubMed ID: 9657034
[TBL] [Abstract][Full Text] [Related]
18. Natural history of superficial bladder cancer. Prognostic features and long-term disease course.
Heney NM
Urol Clin North Am; 1992 Aug; 19(3):429-33. PubMed ID: 1636228
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
20. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
